Virus Specific T-Cell Terminated Phase 1 Trials for Viral Infections / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04401410Anti-SARS Cov-2 T Cell Infusions for COVID 19